BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1521235)

  • 1. Sister chromatid exchange and chromosome breakage in complete hydatidiform moles.
    Becker RA; Surti U; Wenger SL
    Cancer Genet Cytogenet; 1992 Aug; 62(1):53-7. PubMed ID: 1521235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics of trophoblasts from complete hydatidiform moles.
    Habibian R; Surti U
    Cancer Genet Cytogenet; 1987 Dec; 29(2):271-87. PubMed ID: 3677047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromosome instability observed in cells from monospermic, homozygous moles].
    Hoshi S
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):519-27. PubMed ID: 3679082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome and cellular origin of choriocarcinoma.
    Wake N; Tanaka K; Chapman V; Matsui S; Sandberg AA
    Cancer Res; 1981 Aug; 41(8):3137-43. PubMed ID: 7195772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
    Savage J; Adams E; Veras E; Murphy KM; Ronnett BM
    Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic study on the peripheral lymphocytes of patients with trophoblastic tumors following chemotherapy.
    Bian ML; Song HZ; Sun NH; Wang FY; Ning Y
    Chin Med J (Engl); 1984 Jul; 97(7):479-82. PubMed ID: 6441681
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytogenomic studies of hydatiform moles and gestational choriocarcinoma].
    Poaty H; Coullin P; Leguern E; Dessen P; Valent A; Afoutou JM; Peko JF; Candelier JJ; Gombé-Mbalawa C; Picard JY; Bernheim A
    Bull Cancer; 2012 Sep; 99(9):827-43. PubMed ID: 22877883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of hydatidiform mole and choriocarcinoma.
    Bracken MB; Brinton LA; Hayashi K
    Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The propensity to malignancy of dispermic heterozygous moles.
    Wake N; Fujino T; Hoshi S; Shinkai N; Sakai K; Kato H; Hashimoto M; Yasuda T; Yamada H; Ichinoe K
    Placenta; 1987; 8(3):319-26. PubMed ID: 2821529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma.
    Ahmed MN; Kim K; Haddad B; Berchuck A; Qumsiyeh MB
    Cancer Genet Cytogenet; 2000 Jan; 116(1):10-5. PubMed ID: 10616525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical induction of sister chromatid exchange at fragile sites.
    Wenger SL
    Cancer Genet Cytogenet; 1995 Nov; 85(1):72-4. PubMed ID: 8536242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
    Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
    Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically homozygous choriocarcinoma following pregnancy with hydatidiform mole.
    Fisher RA; Lawler SD; Povey S; Bagshawe KD
    Br J Cancer; 1988 Dec; 58(6):788-92. PubMed ID: 2906253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
    Lei ZM; Rao CV; Ackerman DM; Day TG
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
    Wake N; Arima T; Matsuda T
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
    Wake N
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.